Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,638 | 475 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,109 | 84 | $0 (2024) |
| Amgen Inc. | $971.78 | 60 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $962.10 | 20 | $0 (2024) |
| Novo Nordisk Inc | $834.19 | 50 | $0 (2024) |
| Lilly USA, LLC | $650.42 | 55 | $0 (2024) |
| GlaxoSmithKline, LLC. | $502.16 | 30 | $0 (2024) |
| Abbott Laboratories | $450.37 | 20 | $0 (2024) |
| PFIZER INC. | $237.54 | 16 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $224.25 | 7 | $0 (2024) |
| PREVENTRIC DIAGNOSTICS, INC. | $222.85 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,395 | 119 | ABBVIE INC. ($395.99) |
| 2023 | $2,629 | 142 | ABBVIE INC. ($412.43) |
| 2022 | $1,941 | 122 | Abbott Laboratories ($192.81) |
| 2021 | $1,673 | 92 | PREVENTRIC DIAGNOSTICS, INC. ($222.85) |
All Payment Transactions
475 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: VACCINES | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Obesity | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Biological | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $82.87 | General |
| Category: GALLSTONES | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Neurology | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: VACCINE | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $95.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Bone Health | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.15 | General |
| 10/08/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,040 | 1,677 | $215,019 | $67,642 |
| 2022 | 15 | 1,222 | 2,267 | $240,050 | $76,680 |
| 2021 | 19 | 1,326 | 2,353 | $218,554 | $75,928 |
| 2020 | 20 | 1,424 | 2,526 | $207,941 | $69,175 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 282 | 564 | $124,080 | $36,503 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 88 | 121 | $37,510 | $11,395 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 160 | 226 | $35,030 | $10,279 | 29.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 221 | 457 | $2,742 | $2,687 | 98.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $3,150 | $2,231 | 70.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 40 | 40 | $2,600 | $1,581 | 60.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 140 | 145 | $4,495 | $1,372 | 30.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 12 | $1,140 | $591.82 | 51.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 12 | 14 | $1,820 | $460.22 | 25.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 11 | $1,716 | $295.19 | 17.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 30 | 38 | $456.00 | $149.72 | 32.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 28 | $280.00 | $95.48 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 286 | 648 | $139,800 | $41,367 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 172 | 262 | $39,560 | $12,394 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 70 | 95 | $28,550 | $9,918 | 34.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 230 | 414 | $12,834 | $3,935 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 20 | 20 | $3,000 | $2,168 | 72.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 40 | 45 | $4,275 | $2,156 | 50.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 272 | 547 | $3,282 | $1,620 | 49.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 22 | 23 | $1,495 | $938.08 | 62.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 12 | 43 | $1,806 | $592.20 | 32.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 78 | $2,418 | $508.46 | 21.0% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 13 | 13 | $546.00 | $488.63 | 89.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 12 | 13 | $1,690 | $363.90 | 21.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 30 | 32 | $384.00 | $126.68 | 33.0% |
About David Henderson, P.A.-C
David Henderson, P.A.-C is a Medical healthcare provider based in Morehead City, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578582912.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Henderson, P.A.-C has received a total of $8,638 in payments from pharmaceutical and medical device companies, with $2,395 received in 2024. These payments were reported across 475 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($8,638).
As a Medicare-enrolled provider, Henderson has provided services to 5,012 Medicare beneficiaries, totaling 8,823 services with total Medicare billing of $289,425. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Morehead City, NC
- Active Since 07/18/2006
- Last Updated 12/11/2016
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1578582912
Products in Payments
- Wegovy (Drug) $538.66
- VRAYLAR (Drug) $516.92
- EVENITY (Biological) $464.53
- FARXIGA (Drug) $440.27
- MOUNJARO (Drug) $362.75
- BREZTRI (Drug) $323.15
- QULIPTA (Drug) $318.42
- TRELEGY ELLIPTA (Drug) $267.23
- Otezla (Drug) $265.93
- FREESTYLE LIBRE 3 (Device) $237.69
- Kerendia (Drug) $224.25
- UBRELVY (Drug) $223.47
- BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM (Device) $222.85
- JARDIANCE (Drug) $199.34
- FREESTYLE LIBRE 2 (Device) $192.43
- AIRSUPRA (Drug) $169.40
- VOQUEZNA (Drug) $157.66
- REXULTI (Drug) $157.14
- SOLIQUA 100/33 (Biological) $156.25
- SHINGRIX (Biological) $139.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Morehead City
David Taylor
Medical — Payments: $29,906
James Norris
Medical — Payments: $9,233
Lauren Thomas, Pa-C, PA-C
Medical — Payments: $8,528
Leslie Van Dyke, P.a.-C, P.A.-C
Medical — Payments: $1,197
Shanee Savoie, P.a, P.A
Medical — Payments: $1,067
John Wheary, Pa-C, PA-C
Medical — Payments: $995.28